Phase 1 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have been diagnosed with Rheumatoid Arthritis (RA) that started after you turned 18 years old.
- You must meet a specific set of recognized medical guidelines used to confirm a diagnosis of Rheumatoid Arthritis (confirm with trial site).
- You must have at least one visibly swollen joint in your hand or wrist, confirmed by a doctor's examination at two early study visits.
- You must have tried the medication methotrexate (MTX) in the past but not had a good enough response to it.
Who may not be able to join:
- You may not be able to join if you have another serious health condition (such as heart, kidney, liver, lung, nerve, digestive, blood, hormonal, or mental health problems) that the study doctor believes could put you at significant risk by participating.
- You may not be able to join if you have any other condition, apart from RA, that could make it difficult for the study team to properly interpret your results.
- You may not be able to join if your Rheumatoid Arthritis is considered severe, based on a specific scoring system that measures disease activity using a blood test and joint assessment (confirm with trial site).
- There may be additional requirements or restrictions not fully listed here that the trial site will need to review with you.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events (AEs); Number of participants with serious adverse events (SAEs); Number of participants with physical examination findings; Number of participants with vital sign measurement findings; Number of participants with 12-lead electrocardiogram (ECG) findings; Number of participants with clinical laboratory test findings
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.